Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonates in collagen arthritis.

H M Markusse1, G J Lafeber, F C Breedveld

  • 1Department of Rheumatology, University Hospital, Leiden, The Netherlands.

Rheumatology International
|January 1, 1990
PubMed
Summary

Bisphosphonates, including APD and dimethyl-APD, did not reduce arthritis severity or bone destruction in a rat collagen arthritis model. Immune responses remained unchanged, indicating bisphosphonates do not alter this chronic arthritis progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preface.

Seminars in arthritis and rheumatism·2019
Same author

Advances in targeted therapies 2017.

Clinical immunology (Orlando, Fla.)·2018
Same author

Advances in targeted therapies XIII.

Annals of the rheumatic diseases·2012
Same author

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.

Annals of the rheumatic diseases·2012
Same author

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies.

Annals of the rheumatic diseases·2011
Same author

Advances in targeted therapies XII. Preface.

Annals of the rheumatic diseases·2011

Area of Science:

  • Pharmacology
  • Immunology
  • Rheumatology

Background:

  • Bisphosphonates are known to inhibit bone resorption.
  • Their efficacy in inflammatory arthropathies requires further investigation.

Purpose of the Study:

  • To evaluate the therapeutic potential of bisphosphonates in a collagen-induced arthritis model.
  • To assess the impact of 3-amino-hydroxypropylidene-1,1-bisphosphonate (APD) and dimethyl-APD on arthritis development and immune responses.

Main Methods:

  • Rats were immunized to induce chronic arthritis.
  • Animals were treated with APD or dimethyl-APD.
  • Arthritis incidence, severity, immune responses, and bone destruction were assessed.

Main Results:

  • APD and dimethyl-APD treatment did not decrease arthritis incidence or severity.
  • No significant differences were observed in cellular or humoral immune responses.
  • Radiographic analysis showed comparable bone destruction across all groups.

Conclusions:

  • Bisphosphonates do not suppress the progression of collagen-induced arthritis in rats.
  • The study suggests bisphosphonates may not be effective for this specific type of chronic inflammatory arthritis.

Related Experiment Videos